Rapid antigen test for SARS-CoV-2: results of validation and use in real life
- PMID: 36186521
- PMCID: PMC9514382
- DOI: 10.2217/fvl-2022-0045
Rapid antigen test for SARS-CoV-2: results of validation and use in real life
Abstract
Aim: To verify a SARS-CoV-2 rapid antigen test (RAT) compared with PCR. Materials & methods: Validation of RAT included 2295 subjects. Next matching of RAT with the PCR was checked in 13,852 subjects referred to PCR after being positive in RAT. Results: Sensitivity and specificity of RAT were 77.38 and 99.10%, respectively. A 74.60% of RAT positive results were confirmed with PCR. Conclusion: The test met WHO susceptibility criteria in a group of symptomatic subjects. In terms of specificity, it met requirements in all subjects. The concordance of RAT with PCR in real life was in line with our verification data.
Keywords: PCR; RAT; SARS-CoV-2; rapid antigen test; validation.
© 2022 Irena Grmek Kosnik.
References
-
- Arnold L, Stratil J. Strategy for a risk-stratified use of rapid antigen testing: containing the SARS-CoV-2 pandemic by integrating rapid testing into case and contact tracing management. Gesundheitswesen 83, 349–353 (2021). - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous